ANTI-INTEGRIN ANTIBODIES AND USES THEREOF

ANTI-INTEGRIN ANTIBODIES AND USES THEREOF

Anti-integrin antibodies are disclosed. Also disclosed are methods of using the antibodies to treat or prevent disorders such as fibrotic diseases, cancer, ophthalmology disorders, and NAFLD. Further disclosed are methods of selecting an antibody that specifically binds to ανβΐ, or that binds to...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: GARDET Agnes, MULLEN Tracey, GRAFF Christilyn, BLAKELEY Brett, PALMER Christina
Format: Patent
Sprache:eng ; spa
Schlagworte:
CHEMISTRY
METALLURGY
ORGANIC CHEMISTRY
PEPTIDES
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator GARDET Agnes
MULLEN Tracey
GRAFF Christilyn
BLAKELEY Brett
PALMER Christina
description Anti-integrin antibodies are disclosed. Also disclosed are methods of using the antibodies to treat or prevent disorders such as fibrotic diseases, cancer, ophthalmology disorders, and NAFLD. Further disclosed are methods of selecting an antibody that specifically binds to ανβΐ, or that binds to ανβΐ and ανβό, or that binds to one or more members of the RGD sub-family of integrins. Se describen anticuerpos antiintegrina. También se describen métodos de uso de los anticuerpos para tratar o prevenir trastornos tales como enfermedades fibróticas, cáncer, trastornos oftalmológicos y NAFLD. Se describen además métodos para seleccionar un anticuerpo que se une específicamente a avß1, o que se une a avß1 y avß6, o que se une a uno o más miembros de la subfamilia de integrinas RGD.
format Patent
fullrecord <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_MX2021012160A</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>MX2021012160A</sourcerecordid><originalsourceid>FETCH-epo_espacenet_MX2021012160A3</originalsourceid><addsrcrecordid>eNrjZNB09Avx1PX0C3F1D_L0UwDxnPxdPF2DgUwXhdBgICPEwzXI1d-Nh4E1LTGnOJUXSnMzKLm5hjh76KYW5MenFhckJqfmpZbE-0YYGRgZGhgaGZoZOBoTpQgAbbAksw</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>ANTI-INTEGRIN ANTIBODIES AND USES THEREOF</title><source>esp@cenet</source><creator>GARDET Agnes ; MULLEN Tracey ; GRAFF Christilyn ; BLAKELEY Brett ; PALMER Christina</creator><creatorcontrib>GARDET Agnes ; MULLEN Tracey ; GRAFF Christilyn ; BLAKELEY Brett ; PALMER Christina</creatorcontrib><description>Anti-integrin antibodies are disclosed. Also disclosed are methods of using the antibodies to treat or prevent disorders such as fibrotic diseases, cancer, ophthalmology disorders, and NAFLD. Further disclosed are methods of selecting an antibody that specifically binds to ανβΐ, or that binds to ανβΐ and ανβό, or that binds to one or more members of the RGD sub-family of integrins. Se describen anticuerpos antiintegrina. También se describen métodos de uso de los anticuerpos para tratar o prevenir trastornos tales como enfermedades fibróticas, cáncer, trastornos oftalmológicos y NAFLD. Se describen además métodos para seleccionar un anticuerpo que se une específicamente a avß1, o que se une a avß1 y avß6, o que se une a uno o más miembros de la subfamilia de integrinas RGD.</description><language>eng ; spa</language><subject>CHEMISTRY ; METALLURGY ; ORGANIC CHEMISTRY ; PEPTIDES</subject><creationdate>2022</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20220106&amp;DB=EPODOC&amp;CC=MX&amp;NR=2021012160A$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25563,76318</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20220106&amp;DB=EPODOC&amp;CC=MX&amp;NR=2021012160A$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>GARDET Agnes</creatorcontrib><creatorcontrib>MULLEN Tracey</creatorcontrib><creatorcontrib>GRAFF Christilyn</creatorcontrib><creatorcontrib>BLAKELEY Brett</creatorcontrib><creatorcontrib>PALMER Christina</creatorcontrib><title>ANTI-INTEGRIN ANTIBODIES AND USES THEREOF</title><description>Anti-integrin antibodies are disclosed. Also disclosed are methods of using the antibodies to treat or prevent disorders such as fibrotic diseases, cancer, ophthalmology disorders, and NAFLD. Further disclosed are methods of selecting an antibody that specifically binds to ανβΐ, or that binds to ανβΐ and ανβό, or that binds to one or more members of the RGD sub-family of integrins. Se describen anticuerpos antiintegrina. También se describen métodos de uso de los anticuerpos para tratar o prevenir trastornos tales como enfermedades fibróticas, cáncer, trastornos oftalmológicos y NAFLD. Se describen además métodos para seleccionar un anticuerpo que se une específicamente a avß1, o que se une a avß1 y avß6, o que se une a uno o más miembros de la subfamilia de integrinas RGD.</description><subject>CHEMISTRY</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PEPTIDES</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2022</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZNB09Avx1PX0C3F1D_L0UwDxnPxdPF2DgUwXhdBgICPEwzXI1d-Nh4E1LTGnOJUXSnMzKLm5hjh76KYW5MenFhckJqfmpZbE-0YYGRgZGhgaGZoZOBoTpQgAbbAksw</recordid><startdate>20220106</startdate><enddate>20220106</enddate><creator>GARDET Agnes</creator><creator>MULLEN Tracey</creator><creator>GRAFF Christilyn</creator><creator>BLAKELEY Brett</creator><creator>PALMER Christina</creator><scope>EVB</scope></search><sort><creationdate>20220106</creationdate><title>ANTI-INTEGRIN ANTIBODIES AND USES THEREOF</title><author>GARDET Agnes ; MULLEN Tracey ; GRAFF Christilyn ; BLAKELEY Brett ; PALMER Christina</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_MX2021012160A3</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng ; spa</language><creationdate>2022</creationdate><topic>CHEMISTRY</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PEPTIDES</topic><toplevel>online_resources</toplevel><creatorcontrib>GARDET Agnes</creatorcontrib><creatorcontrib>MULLEN Tracey</creatorcontrib><creatorcontrib>GRAFF Christilyn</creatorcontrib><creatorcontrib>BLAKELEY Brett</creatorcontrib><creatorcontrib>PALMER Christina</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>GARDET Agnes</au><au>MULLEN Tracey</au><au>GRAFF Christilyn</au><au>BLAKELEY Brett</au><au>PALMER Christina</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>ANTI-INTEGRIN ANTIBODIES AND USES THEREOF</title><date>2022-01-06</date><risdate>2022</risdate><abstract>Anti-integrin antibodies are disclosed. Also disclosed are methods of using the antibodies to treat or prevent disorders such as fibrotic diseases, cancer, ophthalmology disorders, and NAFLD. Further disclosed are methods of selecting an antibody that specifically binds to ανβΐ, or that binds to ανβΐ and ανβό, or that binds to one or more members of the RGD sub-family of integrins. Se describen anticuerpos antiintegrina. También se describen métodos de uso de los anticuerpos para tratar o prevenir trastornos tales como enfermedades fibróticas, cáncer, trastornos oftalmológicos y NAFLD. Se describen además métodos para seleccionar un anticuerpo que se une específicamente a avß1, o que se une a avß1 y avß6, o que se une a uno o más miembros de la subfamilia de integrinas RGD.</abstract><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language eng ; spa
recordid cdi_epo_espacenet_MX2021012160A
source esp@cenet
subjects CHEMISTRY
METALLURGY
ORGANIC CHEMISTRY
PEPTIDES
title ANTI-INTEGRIN ANTIBODIES AND USES THEREOF
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-10T17%3A45%3A42IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=GARDET%20Agnes&rft.date=2022-01-06&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EMX2021012160A%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true